Android Apple

CHMP backs Boehringer's Spevigo for preventing rare psoriasis flare-ups

By Yahoo! Finance   |   4 months ago
CHMP backs Boehringer's Spevigo for preventing rare psoriasis flare-ups

The CHMP recommends Boehringer Ingelheim's Spevigo for preventing generalised pustular psoriasis (GPP) flares in adults and adolescents. Spevigo targets the IL-36 receptor and treats the underlying cause of GPP.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.